×

Subscribe Today

Get our free articles delivered directly to your email!

Continue reading

Madrigal Pharmaceuticals Inc. (MDGL) NASDAQ

$236.54 (11.99) (-4.82%)

Market Cap: $4.67B

As of 02/23/24 04:00 PM EST. Market closed.

(MDGL)

Madrigal Pharmaceuticals Inc. (MDGL)
NASDAQ

$236.54
(11.99) (-4.82%)

Market Cap: $4.67B

As of 02/23/24 04:00 PM EST. Market closed.

Add to Portfolio

madrigal pharmaceuticals inc. is a biotechnology company based out of calle laguna del marquesado nª 19, nave 16 edificio adriana 1ª planta, polígono industrial la resina (villaverde), madrid, community of madrid, ... read more

madrigal pharmaceuticals inc. is a biotechnology company based out of calle laguna del marquesado nª 19, nave 16 edificio adriana 1ª planta, polígono industrial la resina (villaverde), madrid, community of madrid, spain. read less

COMPANY PROFILE
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
CEO
Rebecca Taub
Full Time Employees
93
CEO Compensation (Base)
$416,666
CEO Compensation (Total)
$5.63M
URL
Address
500 Office Center Dr Ste 400, Pennsylvania, Fort Washington, 19034-3234.
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
CEO
Rebecca Taub
Full Time Employees
93
CEO Compensation (Base)
$416,666
CEO Compensation (Total)
$5.63M
Address
500 Office Center Dr Ste 400, Pennsylvania, Fort Washington, 19034-3234.
PRICE CHART FOR MADRIGAL PHARMACEUTICALS INC
1w
1m
3m
6m
YTD
1y
5y
MAX
From: To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
$248
Previous Close
$248.53
Days Range
$235.08 - $249.98
52 week range
$119.76 - $322.67
Volume
469,255
Avg. Volume (30 days)
647,191
Market Cap
$4.67B
Dividend Yield
-
P/E
-
Shares Outstanding
19,742,646
Open
$248
Previous Close
$248.53
Days Range
$235.08 - $249.98
52 week range
$119.76 - $322.67
Volume
469,255
Avg. Volume (30 days)
647,191
Market Cap
$4.67B
Dividend Yield
-
P/E
-
Shares Outstanding
19,742,646
FINANCIAL STATEMENTS FOR MADRIGAL PHARMACEUTICALS INC
LOADING...

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

INSIDER TRANSACTIONS FOR MADRIGAL PHARMACEUTICALS INC
OwnerRelationshipDateTransactionCost# SharesValue($)Total SharesForm 4
Lynch Brian JosephSVP and General CounselJan 16, 2024 Option Exercise$243.92949231,48014,052Jan 18, 2024, 01:52 PM
FRIEDMAN PAUL ADirectorJan 16, 2023 Option Exercise$243.922,254549,79620,001Jan 18, 2024, 01:47 PM
Taub RebeccaPres., R&D, and CMOJan 16, 2024 Option Exercise$243.921,546377,10015,001Jan 18, 2024, 01:46 PM
Waltermire Robert E.Senior VP, Chief Pharma Dev.Jan 16, 2024 Option Exercise$243.92550134,1565,117Jan 18, 2024, 01:45 PM
Howarth Alex G.Chief Financial OfficerJan 16, 2024 Option Exercise$243.921,067260,26313,934Jan 18, 2024, 01:39 PM
Waltermire Robert E.Senior VP, Chief Pharma Dev.Dec 15, 2023 Option Exercise$87.922,000175,8407,667Dec 18, 2023, 04:30 PM
Waltermire Robert E.Senior VP, Chief Pharma Dev.Dec 14, 2023 Option Exercise$87.922,000175,8407,667Dec 18, 2023, 04:30 PM
Waltermire Robert E.Senior VP, Chief Pharma Dev.Dec 15, 2023 Sale$238.502,000477,0006,667Dec 18, 2023, 04:30 PM
Waltermire Robert E.Senior VP, Chief Pharma Dev.Dec 14, 2023 Sale$232.502,000465,0006,667Dec 18, 2023, 04:30 PM
BAKER BROS. ADVISORS LPDirectorDec 14, 2023 Buy$228.3220,6334,710,8931,793,403Dec 14, 2023, 06:10 PM
BAKER BROS. ADVISORS LPDirectorDec 13, 2023 Buy$219.3981,15917,805,6841,774,294Dec 14, 2023, 06:10 PM
BAKER BROS. ADVISORS LPDirectorDec 12, 2023 Buy$218.3134,5787,548,6161,699,129Dec 14, 2023, 06:09 PM
Waltermire Robert E.Senior VP, Chief Pharma Dev.Dec 13, 2023 Option Exercise$87.922,500219,8008,167Dec 14, 2023, 04:30 PM
Waltermire Robert E.Senior VP, Chief Pharma Dev.Dec 12, 2023 Option Exercise$87.921,300114,2966,967Dec 14, 2023, 04:30 PM
Waltermire Robert E.Senior VP, Chief Pharma Dev.Dec 13, 2023 Sale$225.402,500563,5006,667Dec 14, 2023, 04:30 PM
Waltermire Robert E.Senior VP, Chief Pharma Dev.Dec 12, 2023 Sale$217.851,300283,2006,467Dec 14, 2023, 04:30 PM
Lynch Brian JosephSVP and General CounselDec 05, 2023 Option Exercise$87.091,00087,09016,001Dec 06, 2023, 04:30 PM
Lynch Brian JosephSVP and General CounselDec 04, 2023 Option Exercise$81.161,800146,09016,801Dec 06, 2023, 04:30 PM
Lynch Brian JosephSVP and General CounselDec 04, 2023 Sale$218.871,800393,96416,001Dec 06, 2023, 04:30 PM
Lynch Brian JosephSVP and General CounselDec 05, 2023 Sale$227.331,000227,33015,001Dec 06, 2023, 04:30 PM
Lynch Brian JosephSVP and General CounselNov 29, 2023 Option Exercise$73.754,000295,00019,001Dec 01, 2023, 04:30 PM
Lynch Brian JosephSVP and General CounselNov 30, 2023 Option Exercise$73.753,000221,25018,001Dec 01, 2023, 04:30 PM
Lynch Brian JosephSVP and General CounselNov 30, 2023 Sale$204.583,000613,73017,001Dec 01, 2023, 04:30 PM
Lynch Brian JosephSVP and General CounselNov 29, 2023 Sale$199.194,000796,75018,001Dec 01, 2023, 04:30 PM
BAKER BROS. ADVISORS LPDirectorNov 21, 2023 Buy$188.4764,35012,128,3401,667,104Nov 21, 2023, 06:15 PM
BAKER BROS. ADVISORS LPDirectorNov 20, 2023 Buy$185.7420,7093,846,5751,607,668Nov 21, 2023, 06:14 PM
BAKER BROS. ADVISORS LPDirectorNov 17, 2023 Buy$174.7046,3708,100,7041,588,541Nov 21, 2023, 06:14 PM
BAKER BROS. ADVISORS LPDirectorNov 14, 2023 Buy$156.4234,1885,347,8371,531,757Nov 15, 2023, 05:13 PM
BAKER BROS. ADVISORS LPDirectorNov 15, 2023 Buy$161.9715,1992,461,7211,545,775Nov 15, 2023, 05:13 PM
BAKER BROS. ADVISORS LPDirectorNov 14, 2023 Buy$154.0037,6605,799,6531,500,227Nov 15, 2023, 05:12 PM
BAKER BROS. ADVISORS LPDirectorNov 13, 2023 Buy$143.2169,83910,001,3681,465,494Nov 15, 2023, 05:12 PM
Waltermire Robert E.Senior VP, Chief Pharma Dev.Mar 01, 2023 Option Exercise$87.925,000439,60010,667Mar 02, 2023, 04:30 PM
Waltermire Robert E.Senior VP, Chief Pharma Dev.Feb 28, 2023 Option Exercise$87.925,000439,60010,667Mar 02, 2023, 04:30 PM
Waltermire Robert E.Senior VP, Chief Pharma Dev.Mar 01, 2023 Sale$274.425,0001,372,0818,739Mar 02, 2023, 04:30 PM
Waltermire Robert E.Senior VP, Chief Pharma Dev.Feb 28, 2023 Sale$272.075,0001,360,3579,767Mar 02, 2023, 04:30 PM
Levy Richard SDirectorJan 17, 2023 Option Exercise$103.0222,4892,316,84431,589Jan 19, 2023, 07:57 PM
Levy Richard SDirectorJan 17, 2023 Sale$293.1522,4896,592,68631,489Jan 19, 2023, 07:57 PM
Lynch Brian JosephSVP and General CounselJan 03, 2023 Option Exercise$91.7913,0001,193,27013,000Jan 06, 2023, 09:08 AM
Lynch Brian JosephSVP and General CounselJan 03, 2023 Sale$282.9213,0003,677,97712,400Jan 06, 2023, 09:08 AM
Lynch Brian JosephSVP and General CounselDec 23, 2022 Option Exercise$91.797,000642,5307,000Dec 28, 2022, 08:00 PM
Lynch Brian JosephSVP and General CounselDec 23, 2022 Sale$274.187,0001,919,2316,500Dec 28, 2022, 08:00 PM
Sukhija RemyChief Commercial OfficerDec 23, 2022 Option Exercise$60.2630,0001,807,80030,000Dec 28, 2022, 08:00 PM
Sukhija RemyChief Commercial OfficerDec 23, 2022 Sale$274.1430,0008,224,07329,407Dec 28, 2022, 08:00 PM
BAY CITY CAPITAL LLC10% OwnerAug 19, 2020 Sale$107.647,303786,09542,875Aug 19, 2020, 07:40 PM
BAY CITY CAPITAL LLC10% OwnerAug 18, 2020 Sale$110.0310,1971,121,97650,178Aug 19, 2020, 07:40 PM
BAY CITY CAPITAL LLC10% OwnerAug 17, 2020 Sale$110.7312,5001,384,12560,375Aug 19, 2020, 07:40 PM
CRAVES FRED BDirectorAug 19, 2020 Sale$107.647,303786,09542,875Aug 19, 2020, 07:40 PM
CRAVES FRED BDirectorAug 18, 2020 Sale$110.0310,1971,121,97650,178Aug 19, 2020, 07:40 PM
CRAVES FRED BDirectorAug 17, 2020 Sale$110.7312,5001,384,12560,375Aug 19, 2020, 07:40 PM
MILLIGAN DAVID VDirectorNov 19, 2018 Sale$131.6010,0001,316,00020,000Feb 26, 2020, 06:06 PM
MILLIGAN DAVID VDirectorNov 21, 2018 Sale$112.5420,0002,250,8000Feb 26, 2020, 05:41 PM
BAY CITY CAPITAL LLC10% OwnerDec 13, 2019 Sale$105.471,200,000126,564,0014,089,702Dec 13, 2019, 02:18 PM
CRAVES FRED BDirectorDec 13, 2019 Sale$105.471,200,000126,564,0014,089,702Dec 13, 2019, 02:08 PM
CRAVES FRED BDirectorJun 11, 2018 Sale$287.465,9081,698,314113,472Dec 13, 2019, 01:41 PM
FRIEDMAN PAUL AChief Executive OfficerNov 20, 2018 Buy$117.884,000471,520161,128Nov 23, 2018, 08:53 PM
FRIEDMAN PAUL AChief Executive OfficerNov 19, 2018 Buy$124.004,000496,000157,128Nov 19, 2018, 06:26 PM
CRAVES FRED BDirectorNov 19, 2018 Buy$124.692,000249,387298,067Nov 19, 2018, 06:09 PM
MILLIGAN DAVID VDirectorNov 14, 2018 Option Exercise$16.4610,000164,60030,000Nov 14, 2018, 06:43 PM
MILLIGAN DAVID VDirectorSep 18, 2018 Option Exercise$9.4520,000189,00020,000Sep 19, 2018, 04:25 PM
Schneebaum Marc RChief Financial OfficerJun 11, 2018 Option Exercise$86.647,957689,40951,767Jun 13, 2018, 03:53 PM
Schneebaum Marc RChief Financial OfficerJun 11, 2018 Sale$287.4610,0992,903,05841,668Jun 13, 2018, 03:53 PM
CRAVES FRED BDirectorJun 11, 2018 Sale$287.46280,00080,488,7985,264,382Jun 12, 2018, 09:02 PM
FRIEDMAN PAUL AChief Executive OfficerJun 11, 2018 Sale$287.4673,52621,135,783655,540Jun 12, 2018, 08:56 PM
Taub RebeccaChief Medical Officer, EVP R&DJun 11, 2018 Sale$287.4673,52621,135,783655,540Jun 12, 2018, 08:55 PM
BAY CITY CAPITAL LLCDirectorJun 11, 2018 Sale$287.46280,00080,488,7985,264,382Jun 12, 2018, 08:50 PM
Levy Richard SDirectorAug 23, 2017 Buy$16.122,00032,2369,100Aug 24, 2017, 04:04 PM
Levy Richard SDirectorAug 22, 2017 Buy$16.123,55057,2097,100Aug 23, 2017, 04:03 PM
Levy Richard SDirectorAug 21, 2017 Buy$15.883,55056,3583,550Aug 22, 2017, 04:05 PM
Schor ChenFormer President and CEOJul 22, 2016 Option Exercise$9.4814,250135,09037,178Jul 22, 2016, 05:23 PM
Schneebaum Marc RSVP and CFOJul 22, 2016 Option Exercise$9.488,54881,03519,308Jul 22, 2016, 05:22 PM
Rieder Wendy EFormer SVP, Gen. CounselJul 22, 2016 Option Exercise$9.488,55081,05417,730Jul 22, 2016, 05:18 PM
Gollust Keith RDirectorDec 14, 2015 Sale$0.32300,00096,6901,539,169Dec 15, 2015, 04:34 PM
Gollust Keith RDirectorDec 11, 2015 Sale$0.37300,000111,0301,839,169Dec 15, 2015, 04:34 PM
Gollust Keith RDirectorDec 09, 2015 Sale$0.38145,89255,2352,139,169Dec 09, 2015, 05:00 PM
Gollust Keith RDirectorDec 08, 2015 Sale$0.38300,000114,0602,285,061Dec 09, 2015, 05:00 PM
Gollust Keith RDirectorDec 07, 2015 Sale$0.39300,000115,8302,585,061Dec 09, 2015, 05:00 PM
Kovner BruceDirectorDec 07, 2015 Sale$0.4164261,474,172Dec 08, 2015, 02:09 PM
Kovner BruceDirectorDec 04, 2015 Sale$0.4155,62922,941837,021Dec 08, 2015, 02:09 PM
Kovner BruceDirectorDec 04, 2015 Sale$0.4197,97840,4061,474,236Dec 08, 2015, 02:09 PM
Kovner BruceDirectorDec 08, 2015 Sale$0.37496,015183,526340,970Dec 08, 2015, 02:09 PM
Kovner BruceDirectorDec 08, 2015 Sale$0.37873,624323,241600,548Dec 08, 2015, 02:09 PM
Kovner BruceDirectorDec 07, 2015 Sale$0.413615836,985Dec 08, 2015, 02:09 PM
Kovner BruceDirectorDec 02, 2015 Sale$0.43438,588187,3651,739,608Dec 03, 2015, 05:49 PM
Kovner BruceDirectorDec 01, 2015 Sale$0.43174,09174,8941,236,705Dec 03, 2015, 05:49 PM
Kovner BruceDirectorDec 01, 2015 Sale$0.43306,625131,9102,178,196Dec 03, 2015, 05:49 PM
Kovner BruceDirectorDec 03, 2015 Sale$0.4195,04039,337892,650Dec 03, 2015, 05:49 PM
Kovner BruceDirectorDec 03, 2015 Sale$0.41167,39469,2841,572,214Dec 03, 2015, 05:49 PM
Kovner BruceDirectorDec 02, 2015 Sale$0.43249,015106,379987,690Dec 03, 2015, 05:49 PM
Kovner BruceDirectorNov 27, 2015 Sale$0.50596,132295,0852,893,367Nov 30, 2015, 05:23 PM
Kovner BruceDirectorNov 25, 2015 Sale$0.49544,571265,8051,981,218Nov 30, 2015, 05:23 PM
Kovner BruceDirectorNov 25, 2015 Sale$0.49959,149468,1613,489,499Nov 30, 2015, 05:23 PM
Kovner BruceDirectorNov 30, 2015 Sale$0.43231,959100,5541,410,796Nov 30, 2015, 05:23 PM
Kovner BruceDirectorNov 30, 2015 Sale$0.43408,546177,1052,484,821Nov 30, 2015, 05:23 PM
Kovner BruceDirectorNov 27, 2015 Sale$0.50338,463167,5391,642,755Nov 30, 2015, 05:23 PM
Kovner BruceDirectorNov 24, 2015 Sale$0.44343,246151,4744,448,648Nov 24, 2015, 05:27 PM
Kovner BruceDirectorNov 23, 2015 Sale$0.44230,129100,5432,720,672Nov 24, 2015, 05:27 PM
Kovner BruceDirectorNov 23, 2015 Sale$0.44405,324177,0864,791,894Nov 24, 2015, 05:27 PM
Kovner BruceDirectorNov 24, 2015 Sale$0.44194,88386,0022,525,789Nov 24, 2015, 05:27 PM
Kovner BruceDirectorNov 19, 2015 Sale$0.46115,89653,5095,344,104Nov 20, 2015, 05:42 PM
Kovner BruceDirectorNov 19, 2015 Sale$0.50992,953501,4410Nov 20, 2015, 05:42 PM
Kovner BruceDirectorNov 18, 2015 Sale$0.43108,15446,820992,953Nov 20, 2015, 05:42 PM
Kovner BruceDirectorNov 20, 2015 Sale$0.4483,39736,9532,950,801Nov 20, 2015, 05:42 PM
Kovner BruceDirectorNov 20, 2015 Sale$0.44146,88665,0855,197,218Nov 20, 2015, 05:42 PM
Kovner BruceDirectorNov 19, 2015 Sale$0.4665,80230,3813,034,198Nov 20, 2015, 05:42 PM
Gollust Keith RDirectorNov 17, 2015 Sale$0.41100,00041,4002,885,061Nov 19, 2015, 06:03 PM
Kovner BruceDirectorNov 17, 2015 Sale$0.42700,618295,6611,101,107Nov 17, 2015, 05:08 PM
Kovner BruceDirectorNov 16, 2015 Sale$0.4415,5306,7591,801,725Nov 17, 2015, 05:08 PM
Kovner BruceDirectorNov 13, 2015 Sale$0.43507,788219,5681,817,255Nov 17, 2015, 05:08 PM
Gollust Keith RDirectorNov 10, 2015 Sale$0.55188,322103,0502,985,061Nov 13, 2015, 11:20 AM
Gollust Keith RDirectorNov 10, 2015 Sale$0.55188,322103,0502,985,061Nov 12, 2015, 06:00 PM
Kovner BruceDirectorNov 12, 2015 Sale$0.47733,564347,7832,325,043Nov 12, 2015, 05:19 PM
Kovner BruceDirectorNov 11, 2015 Sale$0.501,080,941538,2013,058,607Nov 12, 2015, 05:19 PM
Kovner BruceDirectorNov 10, 2015 Sale$0.551,397,114769,1114,139,548Nov 12, 2015, 05:19 PM
Kovner BruceDirectorNov 09, 2015 Sale$0.612,225,0541,354,1685,536,662Nov 12, 2015, 05:19 PM
Kovner BruceDirectorApr 06, 2015 Buy$1.756,857,14312,000,00015,278,610Apr 08, 2015, 04:21 PM
Gollust Keith RDirectorApr 06, 2015 Buy$1.75350,000612,5003,173,383Apr 08, 2015, 04:18 PM
WILSON ROBERT NDirectorApr 06, 2015 Buy$1.7550,00087,500754,118Apr 08, 2015, 04:16 PM
Kovner BruceDirectorSep 30, 2014 Buy$3.08300,000923,1308,421,467Oct 01, 2014, 01:56 PM
Kovner BruceDirectorApr 11, 2014 Buy$4.011,250,0005,012,5008,121,467Apr 14, 2014, 07:34 PM
Bernitz Steven BSVP, Corporate DevelopmentDec 18, 2013 Option Exercise$0.0025,000225,000Dec 20, 2013, 04:23 PM
Bahcall Safi RPresident and CEONov 13, 2013 Buy$3.7520,00075,0002,053,135Nov 15, 2013, 06:03 PM
REARDON WILLIAM SDirectorNov 13, 2013 Buy$3.7513,33349,99936,561Nov 15, 2013, 06:01 PM
Gollust Keith RDirectorNov 13, 2013 Buy$3.75150,000562,5002,823,383Nov 15, 2013, 05:58 PM
Kovner BruceDirectorNov 13, 2013 Buy$3.753,400,00012,750,0007,649,803Nov 15, 2013, 05:56 PM
Kovner BruceDirectorNov 13, 2013 Buy$3.751,600,0006,000,0001,600,000Nov 15, 2013, 05:56 PM
Kovner BruceDirectorJun 27, 2013 Buy$4.71150,000706,5153,100,000Jul 01, 2013, 05:55 PM
Bahcall Safi RPresident and CEOJun 28, 2013 Buy$5.0310,00050,2992,033,135Jul 01, 2013, 08:28 AM
Kovner BruceDirectorJun 26, 2013 Buy$4.65300,0001,395,9302,950,000Jun 27, 2013, 05:52 PM
Kovner BruceDirectorJun 25, 2013 Buy$4.35200,000869,4602,650,000Jun 27, 2013, 05:52 PM
Kovner BruceDirectorJun 21, 2013 Buy$4.2350,000211,5202,250,000Jun 25, 2013, 04:42 PM
Kovner BruceDirectorJun 24, 2013 Buy$4.43200,000885,9202,450,000Jun 25, 2013, 04:42 PM
Bahcall Safi RPresident and CEOJun 21, 2013 Buy$4.1220,00082,3742,023,135Jun 24, 2013, 08:01 AM
Kovner BruceDirectorJun 18, 2013 Buy$4.00200,000799,1602,200,000Jun 20, 2013, 04:44 PM
Bahcall Safi RPresident and CEOJun 14, 2013 Buy$4.0510,00040,5502,003,135Jun 17, 2013, 08:02 AM
Bahcall Safi RPresident and CEOJun 06, 2013 Buy$4.0410,00040,3901,993,135Jun 06, 2013, 05:19 PM
Kovner BruceDirectorJun 06, 2013 Buy$4.31738,9003,186,9492,000,000Jun 06, 2013, 05:10 PM
Kovner BruceDirectorJun 05, 2013 Buy$4.71756,0003,561,7431,261,100Jun 06, 2013, 05:10 PM
Kovner BruceDirectorJun 04, 2013 Buy$4.99505,1002,521,661505,100Jun 06, 2013, 05:10 PM
Vukovic VojoSVP, Chief Medical OfficerJun 05, 2013 Buy$4.5810,00045,80035,249Jun 06, 2013, 05:04 PM
WILSON ROBERT NDirectorJun 04, 2013 Buy$5.0010,00050,000699,679Jun 06, 2013, 05:01 PM
Ramachandra SumantPresident, R&DMar 11, 2013 Option Exercise$0.0075,000775,000Mar 13, 2013, 05:53 PM
Gollust Keith RDirectorJan 23, 2013 Option Exercise$8.66114,250989,603316,255Jan 24, 2013, 04:59 PM
WILSON ROBERT NDirectorDec 12, 2012 Option Exercise$8.6058,140500,004689,679Dec 14, 2012, 04:47 PM
KUFE DONALD WDirectorDec 12, 2012 Option Exercise$8.605,81450,00017,748Dec 14, 2012, 04:45 PM
Kovner BruceDirectorDec 12, 2012 Option Exercise$8.602,325,58119,999,9973,273,281Dec 14, 2012, 04:43 PM
Gollust Keith RDirectorDec 12, 2012 Option Exercise$8.60175,0001,505,000175,000Dec 14, 2012, 04:41 PM
Gollust Keith RDirectorDec 12, 2012 Option Exercise$8.6075,000645,0002,673,383Dec 14, 2012, 04:41 PM
Bahcall Safi RPresident and CEODec 12, 2012 Option Exercise$8.6010,00086,0002,383,135Dec 14, 2012, 04:39 PM
Singh AmarSr. VP, Chief Business OfficerNov 29, 2012 Option Exercise$8.213,96932,58521,031Dec 03, 2012, 04:50 PM
Kovner BruceDirectorNov 14, 2012 Buy$6.9510,50073,009947,700Nov 14, 2012, 06:45 PM
Kovner BruceDirectorNov 12, 2012 Buy$6.8927,200187,449937,200Nov 14, 2012, 06:45 PM
Bahcall Safi RPresident and CEONov 12, 2012 Buy$7.1210,00071,2002,373,135Nov 13, 2012, 09:06 AM
KUFE DONALD WDirectorJul 25, 2012 Option Exercise$6.494,62229,99711,934Jul 27, 2012, 04:41 PM
WILSON ROBERT NDirectorJul 25, 2012 Option Exercise$6.49100,000649,000631,539Jul 27, 2012, 04:40 PM
Kovner BruceDirectorJul 25, 2012 Option Exercise$6.493,081,66419,999,9998,006,852Jul 27, 2012, 04:38 PM
Gollust Keith RDirectorJul 25, 2012 Option Exercise$6.49770,4165,000,0002,598,383Jul 27, 2012, 04:36 PM
Bahcall Safi RPresident and CEOJul 25, 2012 Option Exercise$6.4920,000129,8002,363,135Jul 27, 2012, 04:34 PM
Kovner BruceDirectorJun 29, 2012 Buy$5.45910,0004,959,3186,816,048Jul 02, 2012, 04:53 PM
Gollust Keith RDirectorJun 29, 2012 Buy$5.35150,000801,9001,827,967Jul 02, 2012, 02:45 PM
Vukovic VojoSVP, Chief Medical OfficerJun 29, 2012 Buy$5.593,00016,75525,249Jul 02, 2012, 08:53 AM
Bahcall Safi RPresident and CEOJun 29, 2012 Buy$5.3410,00053,3702,343,135Jul 02, 2012, 08:53 AM
Rieder Wendy EVP, IP and Legal, Gen. CounselJun 18, 2012 Option Exercise$2.497,17017,85326,993Jun 20, 2012, 04:08 PM
Rieder Wendy EVP, IP and Legal, Gen. CounselJun 18, 2012 Sale$6.007,17043,02019,823Jun 20, 2012, 04:08 PM
Rieder Wendy EVP, IP and Legal, Gen. CounselJun 04, 2012 Option Exercise$2.497,17017,85326,993Jun 06, 2012, 04:23 PM
Rieder Wendy EVP, IP and Legal, Gen. CounselJun 04, 2012 Sale$5.507,17039,43519,823Jun 06, 2012, 04:23 PM
Vukovic VojoSVP, Chief Medical OfficerMar 01, 2012 Sale$4.702,55512,00622,249Mar 05, 2012, 04:13 PM
Koya KeizoSr. VP, Drug DevelopmentMar 01, 2012 Sale$4.706,84432,18712,999Mar 05, 2012, 04:12 PM
Ehrlich Keith SVP, Fin. and Admin., CFOMar 01, 2012 Sale$4.704,39720,66217,573Mar 05, 2012, 04:12 PM
Kovner BruceDirectorJan 06, 2012 Buy$4.401,136,3634,999,9975,906,048Jan 10, 2012, 04:11 PM
Kovner BruceDirectorDec 07, 2011 Buy$3.9511,05943,7275,269,685Dec 09, 2011, 04:32 PM
Kovner BruceDirectorNov 29, 2011 Buy$3.968,84435,0245,258,626Dec 01, 2011, 04:29 PM
Kovner BruceDirectorNov 25, 2011 Buy$3.9425,01698,4735,249,782Nov 29, 2011, 04:54 PM
Kovner BruceDirectorNov 22, 2011 Buy$3.964531,7935,217,219Nov 25, 2011, 04:12 PM
Kovner BruceDirectorNov 23, 2011 Buy$3.987,54730,0395,224,766Nov 25, 2011, 04:12 PM
Kovner BruceDirectorNov 21, 2011 Buy$3.8433,640129,2995,216,766Nov 22, 2011, 04:44 PM
Kovner BruceDirectorNov 18, 2011 Buy$3.7121,00077,9215,183,126Nov 22, 2011, 04:44 PM
Kovner BruceDirectorSep 12, 2011 Buy$3.8243,085164,4555,162,126Sep 13, 2011, 04:06 PM
Kovner BruceDirectorSep 09, 2011 Buy$3.77110,149415,7025,119,041Sep 13, 2011, 04:06 PM
Kovner BruceDirectorSep 06, 2011 Buy$3.7950,400191,2585,008,892Sep 07, 2011, 04:56 PM
Kovner BruceDirectorSep 02, 2011 Buy$3.8946,057179,2454,958,492Sep 07, 2011, 04:56 PM
Vukovic VojoSVP, Chief Medical OfficerSep 02, 2011 Buy$4.002,1888,75224,804Sep 06, 2011, 04:27 PM
Vukovic VojoSVP, Chief Medical OfficerSep 01, 2011 Buy$4.073121,27022,616Sep 06, 2011, 04:27 PM
Kovner BruceDirectorAug 26, 2011 Buy$3.851003854,912,435Aug 30, 2011, 04:12 PM
Kovner BruceDirectorAug 23, 2011 Buy$3.725,16719,2254,912,335Aug 24, 2011, 04:36 PM
Kovner BruceDirectorAug 22, 2011 Buy$3.7710,59739,9634,907,168Aug 24, 2011, 04:36 PM
Kovner BruceDirectorAug 18, 2011 Buy$3.793,30312,5104,896,569Aug 22, 2011, 04:20 PM
Kovner BruceDirectorAug 08, 2011 Buy$3.7741,700157,3474,806,824Aug 10, 2011, 08:28 PM
Kovner BruceDirectorAug 10, 2011 Buy$3.7033,978125,5934,893,266Aug 10, 2011, 08:28 PM
Kovner BruceDirectorAug 09, 2011 Buy$3.7152,464194,6364,859,288Aug 10, 2011, 08:28 PM
Koya KeizoSr. VP, Drug DevelopmentApr 25, 2011 Sale$6.0010,00060,00019,843Apr 26, 2011, 09:44 PM
Koya KeizoSr. VP, Drug DevelopmentApr 20, 2011 Sale$5.6010,00056,00029,843Apr 26, 2011, 09:44 PM
WILSON ROBERT NDirectorApr 14, 2011 Buy$4.8950,000244,500522,399Apr 18, 2011, 04:09 PM
Gollust Keith RDirectorApr 14, 2011 Buy$4.89100,000489,0001,677,967Apr 18, 2011, 04:05 PM
Kovner BruceDirectorApr 14, 2011 Buy$4.891,431,4937,000,0014,757,266Apr 18, 2011, 04:05 PM
Bahcall Safi RPresident and CEOMar 15, 2011 Buy$4.455,00022,2502,333,135Mar 15, 2011, 02:56 PM
Vukovic VojoSVP, Chief Medical OfficerMar 01, 2011 Sale$5.322,61713,92815,004Mar 03, 2011, 04:33 PM
Rieder Wendy EVP, IP and Legal, Gen. CounselMar 01, 2011 Sale$5.255,28427,76215,426Mar 03, 2011, 04:30 PM
Ehrlich Keith SVP, Fin. and Admin., CFOMar 01, 2011 Sale$5.512,53713,96617,573Mar 03, 2011, 04:26 PM
Koya KeizoSr. VP, Drug DevelopmentMar 01, 2011 Sale$5.2318,27095,55232,999Mar 03, 2011, 04:20 PM
Kovner BruceDirectorNov 10, 2010 Option Exercise$3.471,440,9235,000,0033,325,773Nov 12, 2010, 04:26 PM
Kovner BruceDirectorSep 15, 2010 Buy$3.6424,26488,4111,884,850Sep 17, 2010, 04:15 PM
Kovner BruceDirectorSep 13, 2010 Buy$3.5736,900131,8551,821,750Sep 15, 2010, 04:10 PM
Kovner BruceDirectorSep 14, 2010 Buy$3.7038,836143,6501,860,586Sep 15, 2010, 04:10 PM
Vukovic VojoSVP, Chief Medical OfficerAug 16, 2010 Buy$2.952,8008,26017,621Aug 20, 2010, 10:32 AM
Vukovic VojoSVP, Chief Medical OfficerAug 12, 2010 Buy$2.847142,02814,821Aug 20, 2010, 10:32 AM
BAILEY MICHAEL PSr. VP, Chief Comm. OfficerAug 05, 2010 Sale$3.214,00012,84029,627Aug 06, 2010, 04:41 PM
Load More Insider Transactions
Buy Sale Option Exercise
OwnerRelationshipDateValue($)
Lynch Brian JosephSVP and General Counsel01/16/2024231,480
FRIEDMAN PAUL ADirector01/16/2023549,796
Taub RebeccaPres., R&D, and CMO01/16/2024377,100
Waltermire Robert E.Senior VP, Chief Pharma Dev.01/16/2024134,156
Howarth Alex G.Chief Financial Officer01/16/2024260,263
Waltermire Robert E.Senior VP, Chief Pharma Dev.12/15/2023175,840
Waltermire Robert E.Senior VP, Chief Pharma Dev.12/14/2023175,840
Waltermire Robert E.Senior VP, Chief Pharma Dev.12/15/2023477,000
Waltermire Robert E.Senior VP, Chief Pharma Dev.12/14/2023465,000
BAKER BROS. ADVISORS LPDirector12/14/20234,710,893
BAKER BROS. ADVISORS LPDirector12/13/202317,805,684
BAKER BROS. ADVISORS LPDirector12/12/20237,548,616
Waltermire Robert E.Senior VP, Chief Pharma Dev.12/13/2023219,800
Waltermire Robert E.Senior VP, Chief Pharma Dev.12/12/2023114,296
Waltermire Robert E.Senior VP, Chief Pharma Dev.12/13/2023563,500
Waltermire Robert E.Senior VP, Chief Pharma Dev.12/12/2023283,200
Lynch Brian JosephSVP and General Counsel12/05/202387,090
Lynch Brian JosephSVP and General Counsel12/04/2023146,090
Lynch Brian JosephSVP and General Counsel12/04/2023393,964
Lynch Brian JosephSVP and General Counsel12/05/2023227,330
Lynch Brian JosephSVP and General Counsel11/29/2023295,000
Lynch Brian JosephSVP and General Counsel11/30/2023221,250
Lynch Brian JosephSVP and General Counsel11/30/2023613,730
Lynch Brian JosephSVP and General Counsel11/29/2023796,750
BAKER BROS. ADVISORS LPDirector11/21/202312,128,340
BAKER BROS. ADVISORS LPDirector11/20/20233,846,575
BAKER BROS. ADVISORS LPDirector11/17/20238,100,704
BAKER BROS. ADVISORS LPDirector11/14/20235,347,837
BAKER BROS. ADVISORS LPDirector11/15/20232,461,721
BAKER BROS. ADVISORS LPDirector11/14/20235,799,653
BAKER BROS. ADVISORS LPDirector11/13/202310,001,368
Waltermire Robert E.Senior VP, Chief Pharma Dev.03/01/2023439,600
Waltermire Robert E.Senior VP, Chief Pharma Dev.02/28/2023439,600
Waltermire Robert E.Senior VP, Chief Pharma Dev.03/01/20231,372,081
Waltermire Robert E.Senior VP, Chief Pharma Dev.02/28/20231,360,357
Levy Richard SDirector01/17/20232,316,844
Levy Richard SDirector01/17/20236,592,686
Lynch Brian JosephSVP and General Counsel01/03/20231,193,270
Lynch Brian JosephSVP and General Counsel01/03/20233,677,977
Lynch Brian JosephSVP and General Counsel12/23/2022642,530
Lynch Brian JosephSVP and General Counsel12/23/20221,919,231
Sukhija RemyChief Commercial Officer12/23/20221,807,800
Sukhija RemyChief Commercial Officer12/23/20228,224,073
BAY CITY CAPITAL LLC10% Owner08/19/2020786,095
BAY CITY CAPITAL LLC10% Owner08/18/20201,121,976
BAY CITY CAPITAL LLC10% Owner08/17/20201,384,125
CRAVES FRED BDirector08/19/2020786,095
CRAVES FRED BDirector08/18/20201,121,976
CRAVES FRED BDirector08/17/20201,384,125
MILLIGAN DAVID VDirector11/19/20181,316,000
MILLIGAN DAVID VDirector11/21/20182,250,800
BAY CITY CAPITAL LLC10% Owner12/13/2019126,564,001
CRAVES FRED BDirector12/13/2019126,564,001
CRAVES FRED BDirector06/11/20181,698,314
FRIEDMAN PAUL AChief Executive Officer11/20/2018471,520
FRIEDMAN PAUL AChief Executive Officer11/19/2018496,000
CRAVES FRED BDirector11/19/2018249,387
MILLIGAN DAVID VDirector11/14/2018164,600
MILLIGAN DAVID VDirector09/18/2018189,000
Schneebaum Marc RChief Financial Officer06/11/2018689,409
Schneebaum Marc RChief Financial Officer06/11/20182,903,058
CRAVES FRED BDirector06/11/201880,488,798
FRIEDMAN PAUL AChief Executive Officer06/11/201821,135,783
Taub RebeccaChief Medical Officer, EVP R&D06/11/201821,135,783
BAY CITY CAPITAL LLCDirector06/11/201880,488,798
Levy Richard SDirector08/23/201732,236
Levy Richard SDirector08/22/201757,209
Levy Richard SDirector08/21/201756,358
Schor ChenFormer President and CEO07/22/2016135,090
Schneebaum Marc RSVP and CFO07/22/201681,035
Rieder Wendy EFormer SVP, Gen. Counsel07/22/201681,054
Gollust Keith RDirector12/14/201596,690
Gollust Keith RDirector12/11/2015111,030
Gollust Keith RDirector12/09/201555,235
Gollust Keith RDirector12/08/2015114,060
Gollust Keith RDirector12/07/2015115,830
Kovner BruceDirector12/07/201526
Kovner BruceDirector12/04/201522,941
Kovner BruceDirector12/04/201540,406
Kovner BruceDirector12/08/2015183,526
Kovner BruceDirector12/08/2015323,241
Kovner BruceDirector12/07/201515
Kovner BruceDirector12/02/2015187,365
Kovner BruceDirector12/01/201574,894
Kovner BruceDirector12/01/2015131,910
Kovner BruceDirector12/03/201539,337
Kovner BruceDirector12/03/201569,284
Kovner BruceDirector12/02/2015106,379
Kovner BruceDirector11/27/2015295,085
Kovner BruceDirector11/25/2015265,805
Kovner BruceDirector11/25/2015468,161
Kovner BruceDirector11/30/2015100,554
Kovner BruceDirector11/30/2015177,105
Kovner BruceDirector11/27/2015167,539
Kovner BruceDirector11/24/2015151,474
Kovner BruceDirector11/23/2015100,543
Kovner BruceDirector11/23/2015177,086
Kovner BruceDirector11/24/201586,002
Kovner BruceDirector11/19/201553,509
Kovner BruceDirector11/19/2015501,441
Kovner BruceDirector11/18/201546,820
Kovner BruceDirector11/20/201536,953
Kovner BruceDirector11/20/201565,085
Kovner BruceDirector11/19/201530,381
Gollust Keith RDirector11/17/201541,400
Kovner BruceDirector11/17/2015295,661
Kovner BruceDirector11/16/20156,759
Kovner BruceDirector11/13/2015219,568
Gollust Keith RDirector11/10/2015103,050
Gollust Keith RDirector11/10/2015103,050
Kovner BruceDirector11/12/2015347,783
Kovner BruceDirector11/11/2015538,201
Kovner BruceDirector11/10/2015769,111
Kovner BruceDirector11/09/20151,354,168
Kovner BruceDirector04/06/201512,000,000
Gollust Keith RDirector04/06/2015612,500
WILSON ROBERT NDirector04/06/201587,500
Kovner BruceDirector09/30/2014923,130
Kovner BruceDirector04/11/20145,012,500
Bernitz Steven BSVP, Corporate Development12/18/20132
Bahcall Safi RPresident and CEO11/13/201375,000
REARDON WILLIAM SDirector11/13/201349,999
Gollust Keith RDirector11/13/2013562,500
Kovner BruceDirector11/13/201312,750,000
Kovner BruceDirector11/13/20136,000,000
Kovner BruceDirector06/27/2013706,515
Bahcall Safi RPresident and CEO06/28/201350,299
Kovner BruceDirector06/26/20131,395,930
Kovner BruceDirector06/25/2013869,460
Kovner BruceDirector06/21/2013211,520
Kovner BruceDirector06/24/2013885,920
Bahcall Safi RPresident and CEO06/21/201382,374
Kovner BruceDirector06/18/2013799,160
Bahcall Safi RPresident and CEO06/14/201340,550
Bahcall Safi RPresident and CEO06/06/201340,390
Kovner BruceDirector06/06/20133,186,949
Kovner BruceDirector06/05/20133,561,743
Kovner BruceDirector06/04/20132,521,661
Vukovic VojoSVP, Chief Medical Officer06/05/201345,800
WILSON ROBERT NDirector06/04/201350,000
Ramachandra SumantPresident, R&D03/11/20137
Gollust Keith RDirector01/23/2013989,603
WILSON ROBERT NDirector12/12/2012500,004
KUFE DONALD WDirector12/12/201250,000
Kovner BruceDirector12/12/201219,999,997
Gollust Keith RDirector12/12/20121,505,000
Gollust Keith RDirector12/12/2012645,000
Bahcall Safi RPresident and CEO12/12/201286,000
Singh AmarSr. VP, Chief Business Officer11/29/201232,585
Kovner BruceDirector11/14/201273,009
Kovner BruceDirector11/12/2012187,449
Bahcall Safi RPresident and CEO11/12/201271,200
KUFE DONALD WDirector07/25/201229,997
WILSON ROBERT NDirector07/25/2012649,000
Kovner BruceDirector07/25/201219,999,999
Gollust Keith RDirector07/25/20125,000,000
Bahcall Safi RPresident and CEO07/25/2012129,800
Kovner BruceDirector06/29/20124,959,318
Gollust Keith RDirector06/29/2012801,900
Vukovic VojoSVP, Chief Medical Officer06/29/201216,755
Bahcall Safi RPresident and CEO06/29/201253,370
Rieder Wendy EVP, IP and Legal, Gen. Counsel06/18/201217,853
Rieder Wendy EVP, IP and Legal, Gen. Counsel06/18/201243,020
Rieder Wendy EVP, IP and Legal, Gen. Counsel06/04/201217,853
Rieder Wendy EVP, IP and Legal, Gen. Counsel06/04/201239,435
Vukovic VojoSVP, Chief Medical Officer03/01/201212,006
Koya KeizoSr. VP, Drug Development03/01/201232,187
Ehrlich Keith SVP, Fin. and Admin., CFO03/01/201220,662
Kovner BruceDirector01/06/20124,999,997
Kovner BruceDirector12/07/201143,727
Kovner BruceDirector11/29/201135,024
Kovner BruceDirector11/25/201198,473
Kovner BruceDirector11/22/20111,793
Kovner BruceDirector11/23/201130,039
Kovner BruceDirector11/21/2011129,299
Kovner BruceDirector11/18/201177,921
Kovner BruceDirector09/12/2011164,455
Kovner BruceDirector09/09/2011415,702
Kovner BruceDirector09/06/2011191,258
Kovner BruceDirector09/02/2011179,245
Vukovic VojoSVP, Chief Medical Officer09/02/20118,752
Vukovic VojoSVP, Chief Medical Officer09/01/20111,270
Kovner BruceDirector08/26/2011385
Kovner BruceDirector08/23/201119,225
Kovner BruceDirector08/22/201139,963
Kovner BruceDirector08/18/201112,510
Kovner BruceDirector08/08/2011157,347
Kovner BruceDirector08/10/2011125,593
Kovner BruceDirector08/09/2011194,636
Koya KeizoSr. VP, Drug Development04/25/201160,000
Koya KeizoSr. VP, Drug Development04/20/201156,000
WILSON ROBERT NDirector04/14/2011244,500
Gollust Keith RDirector04/14/2011489,000
Kovner BruceDirector04/14/20117,000,001
Bahcall Safi RPresident and CEO03/15/201122,250
Vukovic VojoSVP, Chief Medical Officer03/01/201113,928
Rieder Wendy EVP, IP and Legal, Gen. Counsel03/01/201127,762
Ehrlich Keith SVP, Fin. and Admin., CFO03/01/201113,966
Koya KeizoSr. VP, Drug Development03/01/201195,552
Kovner BruceDirector11/10/20105,000,003
Kovner BruceDirector09/15/201088,411
Kovner BruceDirector09/13/2010131,855
Kovner BruceDirector09/14/2010143,650
Vukovic VojoSVP, Chief Medical Officer08/16/20108,260
Vukovic VojoSVP, Chief Medical Officer08/12/20102,028
BAILEY MICHAEL PSr. VP, Chief Comm. Officer08/05/201012,840
Load More Insider Transactions
FUNDS WITH A POSITION IN MADRIGAL PHARMACEUTICALS INC
Fund# Shares Owned% of Portfolio% ChangeInvesting Style
BAKER BROS. ADVISORS LP1,969,7985.19%27.49%Other
BLACKROCK INC.1,212,5620.00715%17.41%Other
PAULSON & CO. INC.1,105,74123.09%121.15%Event Driven, Other
GEODE CAPITAL MANAGEMENT, LLC336,2550.00814%13.43%Other
ORBIMED ADVISORS LLC253,3090.79%ExitedOther
RA CAPITAL MANAGEMENT, L.P.204,5000.74%No changeOther
RENAISSANCE TECHNOLOGIES LLC68,0820.02%ExitedOther
D. E. SHAW & CO., INC.34,500 (Call)0.00698%40.82%Other
CANDRIAM S.C.A.27,0000.04%-6.9%Other
BALYASNY ASSET MANAGEMENT L.P.28,2040.0084%ExitedEvent Driven
D. E. SHAW & CO., INC.15,6220.00316%164.15%Other
AQR CAPITAL MANAGEMENT LLC6,1130.00266%-1.81%Other
TUDOR INVESTMENT CORP ET AL4,6920.00687%ExitedEvent Driven, Other
FARALLON CAPITAL MANAGEMENT LLC3,3190.00381%No changeEvent Driven, Value
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)1,2470.00533%NewOther
CHANGE IN SHARES OUTSTANDING FOR MADRIGAL PHARMACEUTICALS INC
STOCK BUYBACKS FOR MADRIGAL PHARMACEUTICALS INC
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
09/30/2023
06/30/2023
0.90%
1Q
09/30/2023
03/31/2023
1.59%
2Q
09/30/2023
12/31/2022
7.18%
3Q
09/30/2023
09/30/2022
8.03%
4Q
09/30/2023
06/30/2022
8.03%
5Q
09/30/2023
03/31/2022
8.03%
6Q
09/30/2023
12/31/2021
8.17%
7Q
09/30/2023
09/30/2021
11.04%
8Q
09/30/2023
06/30/2021
11.50%
9Q
09/30/2023
03/31/2021
16.64%
10Q
09/30/2023
12/31/2020
19.39%
11Q
09/30/2023
09/30/2020
19.60%
12Q
09/30/2023
06/30/2020
19.72%
13Q
09/30/2023
03/31/2020
19.75%
14Q
09/30/2023
12/31/2019
19.75%
15Q
09/30/2023
09/30/2019
19.86%
16Q
Load More

Period of Report: 09/30/2023

10-K/10-Q Filings: View

Previous Period
% Change in Shares
Quarter
06/30/2023
0.90%
1Q
03/31/2023
1.59%
2Q
12/31/2022
7.18%
3Q
09/30/2022
8.03%
4Q
06/30/2022
8.03%
5Q
03/31/2022
8.03%
6Q
12/31/2021
8.17%
7Q
09/30/2021
11.04%
8Q
06/30/2021
11.50%
9Q
03/31/2021
16.64%
10Q
12/31/2020
19.39%
11Q
09/30/2020
19.60%
12Q
06/30/2020
19.72%
13Q
03/31/2020
19.75%
14Q
12/31/2019
19.75%
15Q
09/30/2019
19.86%
16Q
Load More
BUYBACK ANNOUNCEMENT(S) FOR MADRIGAL PHARMACEUTICALS INC
LOADING...